Sequenom Inc (SQNM.OQ)

SQNM.OQ on NASDAQ Stock Exchange Global Select Market

1.55USD
9 Feb 2016
Change (% chg)

-- (--)
Prev Close
$1.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
216,918
52-wk High
$4.80
52-wk Low
$1.11

SQNM.OQ

Chart for SQNM.OQ

About

Sequenom, Inc. (Sequenom) is a life sciences company. The Company serves patients and physicians by providing early patient management information. Its testing focus is principally in prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its wholly... (more)

Overall

Beta: 0.69
Market Cap(Mil.): $183.79
Shares Outstanding(Mil.): 118.57
Dividend: --
Yield (%): --

Financials

  SQNM.OQ Industry Sector
P/E (TTM): 14.41 418.98 38.48
EPS (TTM): 0.11 -- --
ROI: 13.09 3.02 14.34
ROE: -- 3.69 15.17
Search Stocks

Sequenom to cut jobs; seeks liquid biopsy test partners

Genetic testing company Sequenom Inc said on Thursday it will cut 110 jobs, or about 20 percent of its workforce, and will seek partners to commercialize its liquid biopsy test.

07 Jan 2016

UPDATE 1-Sequenom to cut jobs; seeks liquid biopsy test partners

Jan 7 Genetic testing company Sequenom Inc said on Thursday it will cut 110 jobs, or about 20 percent of its workforce, and will seek partners to commercialize its liquid biopsy test.

07 Jan 2016

Sequenom to cut jobs, divest North Carolina operations

Jan 7 Diagnostic device maker Sequenom Inc said on Thursday it will cut 110 jobs, or about 20 percent of its workforce, and divest its North Carolina operations.

07 Jan 2016

U.S. court rejects Sequenom bid to restore prenatal DNA test patent

NEW YORK A U.S. appeals court refused on Wednesday to reconsider its decision invalidating a Sequenom Inc prenatal DNA test patent, a decision that could put in doubt the validity of a wide range of medical and biotechnology patents.

02 Dec 2015

U.S. court rejects Sequenom bid to restore prenatal DNA test patent

NEW YORK A U.S. appeals court refused on Wednesday to reconsider its decision invalidating a Sequenom Inc prenatal DNA test patent, a decision that could put in doubt the validity of a wide range of medical and biotechnology patents.

02 Dec 2015

UPDATE 2-U.S. court rejects Sequenom bid to restore prenatal DNA test patent

NEW YORK, Dec 2 A U.S. appeals court refused on Wednesday to reconsider its decision invalidating a Sequenom Inc prenatal DNA test patent, a decision that could put in doubt the validity of a wide range of medical and biotechnology patents.

02 Dec 2015

U.S. appeals court rejects Sequenom bid to restore prenatal DNA test patent

NEW YORK, Dec 2 In a key decision that could put in doubt the validity of a wide swath of medical and biotechnology patents, a U.S. appeals court on Wednesday refused to reconsider an earlier decision invalidating a Sequenom Inc prenatal DNA test patent, despite conceding it was a "valuable contribution to science."

02 Dec 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks